Opinion: How to disrupt the health misinformation business model

Health misinformation surrounding statins has surged over recent years, fueled by claims that the widely used cholesterol-lowering drugs cause harm to the brain, liver, and muscles. This trend has raised alarms among medical professionals and researchers who warn that such misinformation threatens public health and undermines proven treatments. A new study published in Lancet Digital Health by Oxford researchers offers a potential solution by providing a tool to assess individual risk of muscle-related side effects from statins, aiming to counteract the spread of misleading narratives. The study analyzed the health records of nearly 5.7 million individuals in England to develop a predictive model estimating the likelihood of severe muscle disorders associated with statin use. According to the findings, 99.6% of patients deemed suitable for statin therapy by their general practitioners faced minimal risk of serious muscle complications. The model allows clinicians to offer personalized risk assessments to concerned patients, moving beyond generalized statistics and addressing specific anxieties. Despite the promising implications of the research, experts remain skeptical about its real-world impact. They point to the growing influence of online misinformation, which has created an environment where accurate medical advice struggles to compete with sensationalized content. A Pew Research Center survey from May revealed that 40% of adults rely on social media influencers and podcasts for health information, while half admitted difficulty distinguishing reliable content from falsehoods. This digital landscape has given rise to a lucrative business model centered around health misinformation. Influencers capitalize on public distrust of mainstream medicine by portraying themselves as advocates against a perceived establishment. By fostering an image of authenticity and vulnerability, contrasting sharply with traditional healthcare providers, they cultivate trust and redirect followers toward products ranging from supplements to wellness coaching programs. Revenue streams often stem from exploiting fears related to emerging health threats. For instance, during outbreaks of diseases such as hantavirus and Ebola, certain social media figures quickly promoted unverified cures. More concerning, however, is the encouragement of patients to abandon scientifically validated treatments for chronic illnesses including cancer, heart disease, diabetes, and mental health disorders. Statin medications, which have significantly reduced the incidence of heart attacks and strokes worldwide, represent a prime target for this misinformation campaign. These drugs are cost-effective, extensively researched, and highly effective at reducing LDL cholesterol levels. Their widespread use makes them particularly attractive to those seeking to profit from skepticism toward conventional medicine. Concerns over the proliferation of statin misinformation date back at least to 2019, when a JAMA Cardiology essay highlighted the shift of fear-based medical myths from vaccines to statins. Subsequent data indicates that discussions about statins on platforms like Reddit have increased by approximately 33% each year, with much of the discourse carrying a negative or neutral tone. In 2025, an analysis of cholesterol-related content on TikTok found that over 40% of top-viewed posts contained inaccuracies, with more than a third offering potentially dangerous advice. Many of these posts recommend alternatives to FDA-approved medications, suggesting substances such as fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice. However, extensive research has shown that none of these options effectively reduce LDL cholesterol better than a placebo. A major study linked exposure to negative information about statins with a greater likelihood of patients discontinuing their medication, thereby increasing their risk of experiencing a heart attack or dying prematurely. Efforts to combat this misinformation through platform moderation have yielded limited success. Initiatives such as the Mayo Clinic's collaboration with Dr. Stephen Kopecky on YouTube aim to provide authoritative responses to common misconceptions, yet the scale of the challenge continues to grow. As the lines between health advocacy and commercial interests blur further, the need for robust strategies to protect public health from the consequences of misinformation becomes ever more pressing.